As
this chart from a
landmark study shows, 96.4% of the people hospitalized with
COVID-19 were vitamin D deficient: their blood 25 hydroxyvitamin D ("25OHD")
levels were below 30 nanograms per milliliter (ng/ml):
So the first step to ending the COVID-19 pandemic is to encourage everyone to spend a few minutes daily in the sun, whose light induces the body to produce vitamin D, and/or to take oral vitamin D supplements daily. Raising everyone's vitamin D levels above 30 ng/ml will lower COVID-19 hospitalizations by 96.4%.
When the Delta variant arose in India, its most populous state Uttar Pradesh (population: 220 million) distributed Ivermectin tablets to everyone who tested positive for COVID-19 and to all of their contacts (source). As you can see below, new COVID-19 cases (black line) in Uttar Pradesh plummeted immediately thereafter and reached near zero in just 2 months (only 5% of Uttar Pradesh's population was fully vaccinated by July of 2021):
The Indian states of Goa, Uttarakand, and the National Capital Territory (NCT) of Delhi, which includes the Indian capital, also deployed Ivermectin, and their new COVID-19 cases plummeted 90%, 97%, and 98% respectively in less than 2 months as well (source), and continued to decline. On September 10, 2021, Goa had just 45 new COVID-19 cases and 2 new deaths while Uttarakand had just 20 new cases and zero new death among its 11.4 million inhabitants (source). Here are the new COVID-19 cases and deaths in Delhi:
By contrast, the Indian state of Kerala focused on vaccinating its 35 million inhabitants and attained the highest vaccination rate among all Indian states with a population of at least 10 million. Ivermectin usage was limited to severe cases of COVID-19 until August 5, 2021, and deleted outright from the protocol thereafter (source). Forty five days later on September 15, 2021, 75% of all new COVID-19 cases in India were in Kerala (source), even though it has only 3% of India's population (source). The chart below compares the COVID-19 case rates in Kerala (top) and Uttar Pradesh (bottom):
Having seen what happened in India, Indonesia deployed Ivermectin in July of 2021, and also eradicated COVID-19 in about 2 months (source):
Having seen what happened in India and Indonesia, Japan's Haruo Ozaki, the Chairman of Tokyo Metropolitan Medical Association, held an emergency press conference on August 13, 2021 and announced on national television that Ivermectin should be used against COVID-19. Japan's cases of COVID-19 plummeted shortly thereafter as the Japanese doctors and people heeded his call, and were also eradicated in about 2 months (source):
Countries where Ivermectin was already in wide use have been largely spared the COVID-19 pandemic. Researchers have compared COVID-19 morbidity (sickness) and mortality (death) rates in 31 African countries where Ivermectin was already in wide use vs. 22 African countries where Ivermectin was not already used widely, and reported that the former had 86% lower COVID-19 morbidity and 89% lower COVID-19 mortality rates:
COVID-19 Morbidity Rate |
COVID-19 Mortality Rate |
|
Ivermectin not used widely (22 countries) | 6,473 per million | 122 per million |
Ivermectin used widely (31 countries) | 926 per million | 14 per million |
Reduction with Ivermectin usage | -86% | -89% |
Ivermectin, which the World Health Organization (WHO) recognizes as an "Essential Medicine" for the world (source), is also an exceptionally safe drug. In July of 2021, the cumulative administered doses of COVID-19 vaccines and Ivermectin both reached 3,700,000,000. The deaths and adverse effects reported for both, summarized below, indicate that the risk of death from the vaccines is 53325% higher than from Ivermectin, and the risk of adverse effects from the vaccines is 31832% higher than from Ivermectin:
Reported Since |
Deaths |
Adverse Effects |
Cumulative Doses |
|
Ivermectin | 1992 | 16 | 4,669 | 3.7 billion |
COVID-19 Vaccines | 2021 | 8,532 | 1,490,915 | 3.7 billion |
Difference | +53325% | +31832% | ||
Because the COVID-19 vaccines target just the spike protein of the SARS-CoV-2 virus, as new variants arise with mutations in the spike protein, COVID-19 vaccines will continue to lose their specificity and efficacy. In contrast, because Ivermectin neutralizes the SARS-CoV-2 virus in many, many different ways (see updated details), its efficacy against COVID-19 is variant-independent.
Big Pharma and their proxies claim that Ivermectin shouldn't be used against COVID-19 because its efficacy against COVID-19 has not been proven in a randomized controlled trial (RCT). Their claim is refuted on two fronts. First, a RCT tries to predict how a drug will perform if deployed among the general public. Instead of predicting, the evidences above prove Ivermectin's efficacy when deployed to hundreds of millions of people, so there is no need for a RCT-based prediction or any other prediction. Second, a RCT costs about $20 million to run. Since Ivermectin is a cheap, generic drug that the World Health Organization (WHO) buys for $0.01 per 3 mg tablet, even at a 20% profit margin, a generic drug maker would need to sell 10,000,000,000 tablets ($20 million / $0.002) just to cover the cost of an RCT. Big Pharma know this will never happen, hence their self-serving claim.
When Satoshi Omura and William Campbell shared the 2015 Nobel Prize for Physiology or Medicine for having discovered Ivermectin in 1970, it was the first time in six decades that the prize had been awarded for the discovery of a drug against infectious diseases. In other words, the Nobel Committee for Physiology or Medicine recognized Ivermectin as the most significant new drug discovery against infectious diseases in 60 years.
Blocking the world from the remedy that would have prevented the pandemic and not promoting vitamin D sufficiency, which would have prevented 96.4% of COVID-19 hospitalizations, are crimes that have killed millions of people for the sake of corporate profits. Those who caused and perpetuated these crimes against humanity should be brought to justice, and their ineffective and toxic vaccinations must end. If Ivermectin is deployed worldwide and vitamin D sufficiency is promoted, the COVID-19 pandemic will end in about 2 months.